The report provides a detailed analysis essential for establishing a Zoledronic Acid production plant. It encompasses all critical aspects necessary for Zoledronic Acid production, including the cost of Zoledronic Acid production, Zoledronic Acid plant cost, Zoledronic Acid production costs, and the overall Zoledronic Acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Zoledronic Acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Zoledronic Acid is a bisphosphonate medication that is used to treat and prevent various bone diseases. It is used for the treatment of osteoporosis in postmenopausal women and men at high risk of fractures. It is also utilised for the management of high blood calcium levels caused by cancer (hypercalcemia of malignancy) and prevention of bone complications in cancers like multiple myeloma and bone metastases from solid tumours. It is employed to treat Paget’s disease of bone, a condition that causes bones to become weak and misshapen.
It works by stopping osteoclast-mediated bone resorption, which strengthens the bone density and reduces the risk of fractures. It is administered via intravenous injection and its common side effects include fever, chills, flu-like symptoms, headache, bone, muscle, and joint pain, nausea, vomiting, diarrhoea, constipation, and fatigue.
The market for Zoledronic Acid is driven increasing prevalence of osteoporosis and other bone-related disorders. The growth in ageing populations and rising incidence of cancer with bone metastases, like breast, prostate, and multiple myeloma, boosts its demand. The usage of advanced technology in drug formulations, long-acting injectable delivery systems, and improved patient adherence programs further supports its market expansion.
Also, favourable healthcare policies, government initiatives promoting bone health, and increasing awareness about bone disease prevention contribute to its market growth. The industrial Zoledronic Acid procurement is affected by high drug cost, potential side effects, patent expirations, and competition from generics and alternative therapies.
Raw Material for Zoledronic Acid Production
According to the Zoledronic Acid production plant project report, the key raw materials used in the production of Zoledronic Acid include Imidazol-1-Acetic Acid-Phosphorous Acid-Phosphorus Trichloride.
Production Process of Zoledronic Acid
The extensive Zoledronic Acid production cost report consists of the following major industrial production process:
- From Imidazol-1-Acetic Acid, Phosphorous Acid, and Phosphorus Trichloride: The production process of Zoledronic Acid involves several steps. In this process, phosphorylation of imidazol-1-acetic acid with phosphorous acid and phosphorus trichloride takes place at 40–80 degree for 2–6 hours. After the reaction, it is hydrolysed with hydrochloric acid or purified water. The resulting crude product is separated by filtration, recrystallised from a water-miscible organic solvent (such as isopropanol or ethanol), and dried to obtain pure zoledronic acid as the final product.
Zoledronic Acid has the molecular formula C5H10N2O7P2 and a molecular weight of 272.09 g/mol. It has a melting point of around 238-240 degree Celsius with decomposition. It is highly soluble in water, especially at neutral pH (greater than 290 mg/mL), but insoluble in organic solvents. It has two phosphonate groups and an imidazole ring, which play an important role in its mechanism as a bone resorption inhibitor. It shows polar characteristics with multiple hydrogen bond donors and acceptors, and a polar surface area of around 153 Ų in its monohydrate form. It works by inhibiting enzymes in the mevalonate pathway, leading to apoptosis in osteoclasts. It is used in treating osteoporosis, Paget’s disease of bone, and malignancy-associated bone complications. It is stable under normal storage conditions, usually sealed and stored at room temperature.